Group One Trading
KNSA icon

Group One Trading’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Group One Trading’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-200
Closed -$8.86K – 8197
2025
Q4 		$8.25K Buy
+200
New +$8.02K ﹤0.01% 6918
2025
Q3 		– Sell
-6,969
Closed -$193K – 8772
2025
Q2 		$193K Buy
6,969
+6,161
+763% +$157K ﹤0.01% 4380
2025
Q1 		$17.9K Buy
+808
New +$16.6K ﹤0.01% 5892
2024
Q4 		– Sell
-827
Closed -$18.9K – 7628
2024
Q3 		$20.7K Sell
827
-1,001
-55% -$24.4K ﹤0.01% 5214
2024
Q2 		$34.1K Sell
1,828
-347
-16% -$6.5K ﹤0.01% 4808
2024
Q1 		$42.9K Buy
+2,175
New +$42.5K ﹤0.01% 4834
2022
Q3 		– Sell
-1,276
Closed -$14.5K – 7881
2022
Q2 		$12K Sell
1,276
-4,427
-78% -$41.3K ﹤0.01% 6656
2022
Q1 		$57K Sell
5,703
-3,907
-41% -$41.4K ﹤0.01% 5991
2021
Q4 		$113K Sell
9,610
-17,759
-65% -$218K ﹤0.01% 5627
2021
Q3 		$312K Buy
27,369
+12,947
+90% +$169K ﹤0.01% 4703
2021
Q2 		$201K Buy
14,422
+9,643
+202% +$146K ﹤0.01% 5242
2021
Q1 		$88K Buy
+4,779
New +$97.8K ﹤0.01% 5772

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Group One Trading's KNSA Position: Q1 2026 in Review

Group One Trading sold out of Kiniksa Pharmaceuticals (KNSA) in Q1 2026, closing a stake of 200 shares — an estimated $8.86K sold.

Group One Trading first reported a position in KNSA in Q1 2021 and held it in 12 quarters. The position peaked at $312K in Q3 2021. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Group One Trading reported no remaining Kiniksa Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 200 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $8.86K.
  • Group One Trading first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and held it in 12 quarters.
  • Group One Trading's Kiniksa Pharmaceuticals position peaked at $312K in Q3 2021.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.